Highly pathogenic porcine reproductive and respiratory syndrome virus induces prostaglandin E2 production through cyclooxygenase 1, which is dependent on the ERK1/2-p-C/EBP-β Pathway

Journal of Virology

Volumn 88, Issue 5, 2014, Pages 2810-2820

  Bi, Yanmin ^a   Guo, Xue Kun ^a   Zhao, Haiyan ^a   Gao, Li ^a   Wang, Lianghai ^a   Tang, Jun ^a   Feng, Wen Hai ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROSTAGLANDIN E2;

ANIMAL CELL; ARTERIVIRUS; ARTICLE; BLOOD SAMPLING; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FEVER; GENE SILENCING; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR CLONING; MOLECULAR MECHANICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN BINDING; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; BASE SEQUENCE; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CLONING, MOLECULAR; CYCLOOXYGENASE 1; DINOPROSTONE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; PROMOTER REGIONS, GENETIC; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; SWINE;

EID: 84896719485     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03205-13     Document Type: Article

References (55)

1. Fu Y, Quan R, Zhang H, Hou J, Tang J, Feng WH. 2012. Porcine reproductive and respiratory syndrome virus induces interleukin-15 through the NF-kappaB signaling pathway. J. Virol. 86:7625-7636. http://dx.doi.org/10.1128/JVI.00177-12.
2. Balasuriya UB, MacLachlan NJ. 2004. The immune response to equine arteritis virus:potential lessons for other arteriviruses. Vet. Immunol. Immunopathol. 102:107-129. http://dx.doi.org/10.1016/j.vetimm.2004.09 .003.
3. Zhou Y, Yang X, Wang HN, Zhang A, Zhang Z, Kang R, Zeng F, Li H. 2012. Molecular characterization of a complete genome and 12 Nsp2 genes of PRRSV of southwestern China. Food Environ. Virol. 4:102-114. http://dx.doi.org/10.1007/s12560-012-9083-z.
4. Kim DY, Calvert JG, Chang KO, Horlen K, Kerrigan M, Rowland RR. 2007. Expression and stability of foreign tags inserted into nsp2 of porcine reproductive and respiratory syndrome virus (PRRSV). Virus Res. 128:106-114. http://dx.doi.org/10.1016/j.virusres.2007.04.019.
5. Liu XD, Chen HB, Tong Q, Li XY, Zhu MJ, Wu ZF, Zhou R, Zhao SH. 2011. Molecular characterization of caveolin-1 in pigs infected with Haemophilus parasuis. J. Immunol. 186:3031-3046. http://dx.doi.org/10 .4049/jimmunol.0902687.
6. Guo XK, Zhang Q, Gao L, Li N, Chen XX, Feng WH. 2013. Increasing expression of microRNA 181 inhibits porcine reproductive and respiratory syndrome virus replication and has implications for controlling virus infection. J. Virol. 87:1159-1171. http://dx.doi.org/10.1128/JVI.02386-12.
7. Wernike K, Hoffmann B, Dauber M, Lange E, Schirrmeier H, Beer M. 2012. Detection and typing of highly pathogenic porcine reproductive and respiratory syndrome virus by multiplex real-time RT-PCR. PLoS One 7:e38251. http://dx.doi.org/10.1371/journal.pone.0038251.
8. Sivier V, Odelin MF, Gonthier R, Pozzetto B. 2001. Viral respiratory infections as cause of fever in hospitalized aged patients during a winter season. Rev. Med. Interne 22:1180-1187. doi:(In French.) http://dx.doi .org/10.1016/S0248-8663(01)00489-1.
9. Rasoul-Rockenschaub S, Zielinski CC, Muller C, Tichatschek E, Popow-Kraupp T, Kunz C. 1990. Viral reactivation as a cause of unexplained fever in patients with progressive metastatic breast cancer. Cancer Immunol. Immunother. 31:191-195. http://dx.doi.org/10.1007/BF01744736.
10. Guilherme L, Kalil J. 2007. Rheumatic fever:from innate to acquired immune response. Ann. N. Y. Acad. Sci. 1107:426-433. http://dx.doi.org /10.1196/annals.1381.045.
11. 2 and endotoxic fever:a re-assessment. Prostaglandins Other Lipid Mediat. 76:1-18. http://dx.doi.org/10.1016/j.prostaglandins.2005.01.001.
12. Dinarello CA, Wolff SM. 1982. Molecular basis of fever in humans. Am. J. Med. 72:799-819. http://dx.doi.org/10.1016/0002-9343(82)90548-4.
13. 2/P450arom signaling pathway in endometrial carcinoma cells:HER-2/neu gene expression in endometrial carcinoma cells. J. Exp. Clin. Cancer Res. 32:11. http://dx.doi .org/10.1186/1756-9966-32-11.
14. 2. Am. J. Physiol. Gastrointest. Liver Physiol. 288:G39-G47. http://dx.doi .org/10.1152/ajpgi.00060.2004.
15. 2 reduces arachidonic acid release in murine podocytes:evidence for an autocrine feedback loop. Am. J. Physiol. Cell Physiol. 284:C302-C309. http://dx.doi.org/10.1152 /ajpcell.00024.2002.
16. 2 receptor subtype EP1 antagonist may inhibit central interleukin-1beta-induced fever in rats. Am. J. Physiol. 275:R1762-R1765.
17. 2 fever. Am. J. Physiol. 272:R1664-R1669.
18. 2 as a mediator of fever:the role of prostaglandin E (EP) receptors. Front. Biosci. 9:3046-3057. http://dx.doi.org/10 .2741/1458.
19. Steiner AA, Ivanov AI, Serrats J, Hosokawa H, Phayre AN, Robbins JR, Roberts JL, Kobayashi S, Matsumura K, Sawchenko PE, Romanovsky AA. 2006. Cellular and molecular bases of the initiation of fever. PLoS Biol. 4:e284. http://dx.doi.org/10.1371/journal.pbio.0040284.
20. Zhang YH, Lu J, Elmquist JK, Saper CB. 2003. Specific roles of cyclooxygenase-1 and cyclooxygenase-2 in lipopolysaccharide-induced fever and Fos expression in rat brain. J. Comp. Neurol. 463:3-12. http://dx.doi.org/10.1002/cne.10743.
21. 2 in human bronchial smooth-muscle cells. Am. J. Respir. Crit. Care Med. 155:864-868. http://dx.doi.org/10.1164/ajrccm.155.3.9117018.
22. 2 production in astrocytes. J. Biol. Chem. 287:6454-6468. http://dx.doi.org/10.1074/jbc.M111.327874.
23. Chen JX, Berry LC, Christman BW, Meyrick B. 2003. Glutathione mediates LPS-stimulated COX-2 expression via early transient p42/44 MAPK activation. J. Cell. Physiol. 197:86-93. http://dx.doi.org/10.1002 /jcp.10353.
24. Zauli G, Pandolfi A, Gonelli A, Di Pietro R, Guarnieri S, Ciabattoni G, Rana R, Vitale M, Secchiero P. 2003. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells. Circ. Res. 92:732-740. http://dx.doi.org/10.1161/01.RES.0000067928.83455.9C.
25. Jana B, Kozlowska A, Koszykowska M, Majewski M. 2009. Expression of cyclooxygenase-2 in the inflammatory changed porcine uterus. Polish J. Vet. Sci. 12:1-8.
26. Studzinski GP, Wang X, Ji Y, Wang Q, Zhang Y, Kutner A, Harrison JS. 2005. The rationale for deltanoids in therapy for myeloid leukemia:role of KSR-MAPK-C/EBP pathway. J. Steroid Biochem. Mol. Biol. 97:47-55. http://dx.doi.org/10.1016/j.jsbmb.2005.06.010.
27. Belmonte N, Phillips BW, Massiera F, Villageois P, Wdziekonski B, Saint-Marc P, Nichols J, Aubert J, Saeki K, Yuo A, Narumiya S, Ailhaud G, Dani C. 2001. Activation of extracellular signal-regulated kinases and CREB/ATF-1 mediate the expression of CCAAT/enhancer binding proteins beta and-delta in preadipocytes. Mol. Endocrinol. 15:2037-2049. http://dx.doi.org/10.1210/me.15.11.2037.
28. Liu YW, Wang SA, Hsu TY, Chen TA, Chang WC, Hung JJ. 2010. Inhibition of LPS-induced C/EBP delta by trichostatin A has a positive effect on LPS-induced cyclooxygenase 2 expression in RAW264.7 cells. J. Cell. Biochem. 110:1430-1438. http://dx.doi.org/10.1002/jcb.22682.
29. Lai CS, Lee JH, Ho CT, Liu CB, Wang JM, Wang YJ, Pan MH. 2009. Rosmanol potently inhibits lipopolysaccharide-induced iNOS and COX-2 expression through downregulating MAPK, NF-kappaB, STAT3 and C/EBP signaling pathways. J. Agric. Food Chem. 57:10990-10998. http://dx.doi.org/10.1021/jf9025713.
30. Caivano M, Gorgoni B, Cohen P, Poli V. 2001. The induction of cyclooxygenase-2mRNAin macrophages is biphasic and requires bothCCAAT enhancer-binding protein beta (C/EBP beta) and C/EBP delta transcription factors. J. Biol. Chem. 276:48693-48701. http://dx.doi.org/10.1074 /jbc.M108282200.
31. 2 enhances the sensitizing effect of hyperthermia on pulmonary C-fibers in rats. Respir. Physiol. Neurobiol. 156:241-249. http://dx.doi.org/10.1016/j.resp.2006.11.003.
32. 2 attenuation of sheep lung responses to endotoxin. J. Appl. Physiol. 64:2568-2574.
33. 2 and cAMP and suppresses fibroblast proliferation and collagen production. J. Biol. Chem. 257:8098-8105.
34. Hasday JD, Shah N, Mackowiak PA, Tulapurkar M, Nagarsekar A, Singh I. 2011. Fever, hyperthermia, and the lung:it's all about context and timing. Trans. Am. Clin. Climatol. Assoc. 122:34-47.
35. Brant KA, Fabisiak JP. 2009. Nickel and the microbial toxin, MALP-2, stimulate proangiogenic mediators from human lung fibroblasts via a HIF-1alpha and COX-2-mediated pathway. Toxicol. Sci. 107:227-237. http://dx.doi.org/10.1093/toxsci/kfn208.
36. Miyauchi M, Hiraoka M, Oka H, Sato S, Kudo Y, Ogawa I, Noguchi K, Ishikawa I, Takata T. 2004. Immuno-localization of COX-1 and COX-2 in the rat molar periodontal tissue after topical application of lipopolysaccharide. Arch. Oral Biol. 49:739-746. http://dx.doi.org/10.1016/j.archoralbio.2004.04.004.
37. Zidar N, Odar K, Glavac D, Jerse M, Zupanc T, Stajer D. 2009. Cyclooxygenase in normal human tissues-is COX-1 really a constitutive isoform, and COX-2 an inducible isoform? J. Cell. Mol. Med. 13:3753-3763. http://dx.doi.org/10.1111/j.1582-4934.2008.00430.x.
38. Carey MA, Bradbury JA, Rebolloso YD, Graves JP, Zeldin DC, Germolec DR. 2010. Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice. PLoS One 5:e11610. http://dx.doi.org/10.1371/journal.pone.0011610.
39. 2 of macrophage origin. J. Leukoc. Biol. 80:125-132. http://dx.doi.org/10.1189/jlb.0106013.
40. Giovanni G, Giovanni P. 2002. Do non-steroidal anti-inflammatory drugs and COX-2 selective inhibitors have different renal effects?. J. Nephrol. 15:480-488.
41. 2 synthase. Adv. Exp. Med. Biol. 507:457-462. http://dx.doi.org/10.1007/978-1-4615-0193-0_71.
42. 2 in human skin. Am. J. Physiol. 270:C1037-C1050.
43. 2 from arachidonic acid in bronchial epithelial cells. Clin. Exp. Allergy 33:1244-1251. http://dx.doi.org/10.1046/j.1365-2222.2003.01750.x.
44. 2. Trends Immunol. 25:40-46. http://dx.doi.org/10.1016/j.it.2003.11.001.
45. Radi ZA, Meyerholz DK, Ackermann MR. 2010. Pulmonary cyclooxygenase-1 (COX-1) and COX-2 cellular expression and distribution after respiratory syncytial virus and parainfluenza virus infection. Viral Immunol. 23:43-48. http://dx.doi.org/10.1089/vim.2009.0042.
46. Gilroy DW, Tomlinson A, Willoughby DA. 1998. Differential effects of inhibition of isoforms of cyclooxygenase (COX-1, COX-2) in chronic inflammation. Inflamm. Res. 47:79-85. http://dx.doi.org/10.1007/s000110050285.
47. Lipsky PE. 1999. Specific COX-2 inhibitors in arthritis, oncology, and beyond:where is the science headed? J. Rheumatol. Suppl. 56:25-30.
48. Soslow RA, Dannenberg AJ, Rush D, Woerner BM, Khan KN, Masferrer J, Koki AT. 2000. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 89:2637-2645. http://dx.doi.org/10.1002 /1097-0142(20001215)89:122637::AID-CNCR173.0.CO;2-B.
49. Bottone FG, Jr, Martinez JM, Alston-Mills B, Eling TE. 2004. Gene modulation by Cox-1 and Cox-2 specific inhibitors in human colorectal carcinoma cancer cells. Carcinogenesis 25:349-357. http://dx.doi.org/10.1093/carcin/bgh016.
50. Tanaka A, Araki H, Hase S, Komoike Y, Takeuchi K. 2002. Upregulation of COX-2 by inhibition of COX-1 in the rat:a key to NSAIDinduced gastric injury. Aliment. Pharmacol. Ther. 16(Suppl. 2):90-101. http://dx.doi.org/10.1046/j.1365-2036.16.s2.22.x.
51. 2 production by microglia. J. Neuroimmunol. 172:112-120. http://dx.doi.org/10.1016/j.jneuroim.2005.11.008.
52. 2) formation involves the ERKcytosolic phospholipase A2-COX-1-microsomal PGE synthase-1 cascade in human lung epithelial cells. Cell Biochem. Funct. 26:279-282. http://dx.doi.org/10.1002/cbf.1434.
53. Sandee D, Sivanuntakorn S, Vichai V, Kramyu J, Kirtikara K. 2009. Up-regulation of microsomal prostaglandin E synthase-1 in COX-1 and COX-2 knock-out mouse fibroblast cell lines. Prostaglandins Other Lipid Mediat. 88:111-116. http://dx.doi.org/10.1016/j.prostaglandins.2008.12.001.
54. Son DS, Wilson AJ, Parl AK, Khabele D. 2010. The effects of the histone deacetylase inhibitor romidepsin (FK228) are enhanced by aspirin (ASA) in COX-1 positive ovarian cancer cells through augmentation of p21. Cancer Biol. Ther. 9:928-935. http://dx.doi.org/10.4161/cbt.9.11.11873.
55. Lacroix S, Rivest S. 1998. Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain. J. Neurochem. 70:452-466.